Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
Bristol-Myers Squibb
Bristol-Myers Squibb
SWOG Cancer Research Network
PrECOG, LLC.
Fundación GECP
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Bristol-Myers Squibb
West China Hospital
Zhejiang Cancer Hospital
Shanghai Chest Hospital
IRCCS San Raffaele
Taproot Health
Shanghai Chest Hospital
Capital Medical University
The First People's Hospital of Neijiang
Hunan Province Tumor Hospital
Sun Yat-sen University
Persephone Biosciences
Hebei Medical University Fourth Hospital
The First Hospital of Jilin University
The First Hospital of Jilin University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Sykehuset i Vestfold HF
Fuzhou General Hospital
Peking Union Medical College Hospital
Shanghai University of Traditional Chinese Medicine
Medias Klinikum for Surgical Oncology